HR-19011
Based on 1 Customer Validation
HR-19011 is an eIF2α phosphorylation activator targeting heme-regulated inhibitor HRI (EIF2AK1). HR-19011 exhibits growth inhibitory activity against K562 cells with an IC50 value of 3.91 µM. HR-19011 inhibits the growth of hematologic malignancies by targeting HRI to activate the integrated stress response via the HRI-eIF2α-ATF4 axis. HR-19011 shows good safety in vivo. HR-19011 can be used for research on hematologic malignancies (leukemia).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.64%
- CAS 番号: 2851820-52-3
- 分子式: C25H19F6N3O3
- 分子量:523.43
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-147832
EIF2α activator 2EIF2α Activator -
HY-100877
GCN2-IN-1GCN2 Inhibitor -
HY-19831A
(Z)-4EGI-1eIF4E/eIF4G Interaction Inhibitor -
HY-112654
GCN2iBGCN2 Kinase Inhibitor -
HY-33838
eIF4A3-IN-8eIF4A3 Negative Control -
HY-12495
ISRIB (trans-isomer)PERK Inhiitor -
HY-125021
2BActeIF2B Activator -
HY-101991
ML291UPR Signaling Activator -
HY-13977A
PKR-IN-C16PKR Inhibitor -
HY-148443
eIF4A3-IN-9eIF4F Inhibitor -
HY-148452
eIF4A3-IN-18eIF4F Inhibitor -
HY-12495A
ISRIBInhibitor of Integrated Stress Response
生物活性
製品説明
IC50 & Target
|
eIF2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| K562 | IC50 |
4 μM
Compound: 40
|
Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 assay
|
[PMID: 35716517] |
| PBMC | IC50 |
19.3 μM
Compound: 40
|
Antiproliferative activity against human PBMC cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human PBMC cells incubated for 72 hrs by CCK8 assay
|
[PMID: 35716517] |
体外実験
HR-19011 (compound 40) (1.25-20 μM, 72 h) shows an anticancer activity with IC50 values of 4 and 19.3 μM in K562 and human peripheral blood mononuclear cells (PBMC) cell, shows a strong cancer cell selectivity with a SI value of 4.83 in PBMC cells[1].
HR-19011 (0-10 μM, 24 h) activate eIF2α phosphorylation in an eIF2α/ATF4/CHOP pathway-dependent manner in K562 cells[1].
HR9011 exhibits cell growth inhibitory activity with an IC50 value of 3.91 µM in K562 cells transfected with nontargeting control shRNA, while the IC50 value increases to 8.03 µM in K562 cells stably transfected with HRI-specific shRNA[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:K562 cells
-
Concentration:0, 2.5, 5 and 10 μM
-
Incubation Time:24 h
-
Result:Significantly increased the phosphorylation levels of eIF2α in a dose dependent manner.
Upregulated the expression of the downstream effector proteins ATF4 and CHOP.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 2851820-52-3
-
性状 Solid
-
分子量 523.43
-
分子式 C25H19F6N3O3
-
Color White to yellow
-
SMILES
N#CC1=CC(C(F)(F)F)=CC(NC2=C(C(C2=O)=O)N[C@@H]3CC[C@@H](OC4=CC=C(C=C4)C(F)(F)F)CC3)=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
体外:
DMSO : 25 mg/mL (47.76 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (277 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9105 mL | 9.5524 mL | 19.1048 mL | 47.7619 mL |
| 5 mM | 0.3821 mL | 1.9105 mL | 3.8210 mL | 9.5524 mL | |
| 10 mM | 0.1910 mL | 0.9552 mL | 1.9105 mL | 4.7762 mL | |
| 15 mM | 0.1274 mL | 0.6368 mL | 1.2737 mL | 3.1841 mL | |
| 20 mM | 0.0955 mL | 0.4776 mL | 0.9552 mL | 2.3881 mL | |
| 25 mM | 0.0764 mL | 0.3821 mL | 0.7642 mL | 1.9105 mL | |
| 30 mM | 0.0637 mL | 0.3184 mL | 0.6368 mL | 1.5921 mL | |
| 40 mM | 0.0478 mL | 0.2388 mL | 0.4776 mL | 1.1940 mL |
HR-19011 関連分類
HY-147831 関連分類
Powered by Bioz